What is the management of Turner syndrome?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Turner Syndrome

Turner syndrome management requires a comprehensive multidisciplinary approach focusing on cardiovascular monitoring, growth hormone therapy, hormone replacement, and surveillance for associated conditions to reduce mortality and improve quality of life.

Cardiovascular Management

Cardiovascular complications are a major cause of mortality in Turner syndrome:

  • Initial Cardiovascular Assessment:

    • Transthoracic echocardiography (TTE) and cardiac MRI at diagnosis 1
    • Calculate Aortic Size Index (ASI) in patients ≥15 years old 1
    • Screen for bicuspid aortic valve (10-25% prevalence) and aortic coarctation (8% prevalence) 2, 1
  • Risk Stratification and Monitoring:

    • High risk: ASI ≥2.5 cm/m², history of aortic coarctation, or uncontrolled hypertension → annual evaluation 1
    • Moderate risk: ASI 2.0-2.3 cm/m² → evaluation every 3-5 years 1
    • Low risk: ASI <2.0 cm/m² → evaluation every 5-10 years 1
    • Patients with no risk factors (no bicuspid valve, coarctation, or dilated aorta) → re-evaluation every 5-10 years 2
  • Interventions:

    • Beta-blockers to reduce rate of aortic dilatation 1
    • Surgical intervention for aortic root/ascending aorta replacement when ASI ≥2.5 cm/m² plus risk factors 1
    • Strict blood pressure control and monitoring 2, 1

Growth Management

  • Growth Hormone Therapy:
    • Initiate as soon as growth curve falls below 5th percentile 3
    • Adjust doses according to clinical response 3
    • Some studies support combined therapy with growth hormone and oxandrolone (an anabolic steroid) 3
    • Growth hormone treatment has not shown evidence of left ventricular hypertrophy 2

Reproductive and Hormonal Management

  • Estrogen Replacement Therapy:

    • Begin by adolescence for pubertal development 4
    • Timing should balance potential growth impact with need for feminization and bone mineral density protection 3
    • Continue into adulthood to prevent osteoporosis 4
  • Fertility Considerations:

    • Most women with Turner syndrome are infertile 4
    • Assisted reproduction may be an option for some patients 4
    • Pre-pregnancy cardiovascular assessment is essential 1
    • Pregnancy is high-risk and requires close monitoring 1

Surveillance for Associated Conditions

  • Endocrine Disorders:

    • Regular screening for hypothyroidism 5
    • Monitoring for type 1 and type 2 diabetes mellitus 6
    • Bone density assessment for osteoporosis 6, 5
  • Other Systems:

    • Renal imaging to detect malformations 4
    • Hearing assessment for sensorineural hearing loss 4
    • Screening for autoimmune disorders 6, 7

Transition of Care

  • Coordinated transition from pediatric to adult care is crucial to prevent loss of lifelong surveillance 1
  • Adult patients should be followed by a multidisciplinary team including endocrinology, cardiology, gynecology, and other specialists as needed 5

Important Considerations and Pitfalls

  • Diagnostic Delay: Despite characteristic features, average age at diagnosis is around 15 years 6, 7
  • Cardiovascular Risk: Aortic dissection risk is significantly elevated (36:100,000 Turner syndrome years vs. 6:100,000 in general population) 2, 1
  • Pregnancy Risks: Women with Turner syndrome face substantial risks during pregnancy and require specialized pre-conception counseling and monitoring 1
  • Psychosocial Support: Patients may have normal intelligence but experience challenges with nonverbal, social, and psychomotor skills requiring appropriate support 4

Turner syndrome management requires vigilant lifelong monitoring with particular attention to cardiovascular risk, which represents the most significant threat to mortality in these patients.

References

Guideline

Cardiovascular Risk Stratification

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Growth and puberty in Turner's syndrome.

Journal of pediatric endocrinology & metabolism : JPEM, 2003

Research

Turner syndrome: diagnosis and management.

American family physician, 2007

Research

Turner's syndrome in adulthood.

Endocrine reviews, 2002

Research

Turner syndrome: mechanisms and management.

Nature reviews. Endocrinology, 2019

Research

The Changing Face of Turner Syndrome.

Endocrine reviews, 2023

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.